Healthcare Tips: Novartis copy of Amgen arthritis drug highly similar: FDA staff

(Reuters) - Novartis AG's cheaper version of Amgen Inc's blockbuster arthritis drug Enbrel is highly similar in potency and safety to the original, according to a review by Food and Drug Administration staff.

Read more: Novartis copy of Amgen arthritis drug highly similar: FDA staff